News - Markets & Marketing, Dermatologicals


Popular Filters

New psoriasis therapies go head-to-head with existing drugs


Three promising new drug classes are heating up the market for moderate-to-severe plaque psoriasis therapeutics,…

AlphaCytokinesDermatologicalsGlobalImmunologyMarkets & MarketingModerate-to-severe plaque psoriasisPharmaceuticalPharmacology

Free drug samples can change prescribing habits of US dermatologists


The availability of free medication samples in dermatology offices in the USA appears to change prescribing…

DermatologicalsMarkets & MarketingPharmaceuticalUSA

Systemic psoriasis market forecast to reach $10.4 billion by 2020


The systemic psoriasis treatment market value in the eight major countries (8MM) - the USA, Canada, France,…

AmgenapremilastBiotechnologybrodalumabCelgeneDermatologicalsEli LillyMarkets & MarketingNovartisPfizersecukinumabXeljanz

Janssen’s psoriasis drug Stelara set to generate $1.4 billion by 2015

Janssen’s psoriasis drug Stelara set to generate $1.4 billion by 2015


Psoriasis drug Stelara (ustekinumab), from US health care giant Johnson & Johnson’s subsidiary Janssen…

BiotechnologyDermatologicalsJanssen BiotechMarkets & MarketingStelara InjectionUSA

Bayer’s Diane-35 back on French market

Bayer’s Diane-35 back on French market


Following the confirmation of the positive benefit-risk profile by the European Medicines Agency, German…

BayerDermatologicalsDiane-35EuropeFranceMarkets & MarketingPharmaceutical

Kyowa Hakko and LEO Pharma partner on topical calcipotriol/betamethasone dipropionate in Japan


Japanese drugmaker Kyowa Hakko Kirin and Denmark’s privately-held dermatology specialist LEO Pharma…

Asia-PacificBetamethasone DipropionatecalcipotriolDermatologicalsKyowa Hakko KirinLEO PharmaLicensingMarkets & MarketingPharmaceutical

New products will grow atopic dermatitis market to $5.6 billion by 2022

New products will grow atopic dermatitis market to $5.6 billion by 2022


Atopic dermatitis therapeutic sales in nine major global markets are forecast to increase from $3.9 billion…

Anacor PharmaceuticalsChinaDermatologicalsdupilumabEuropeIndiaMarkets & MarketingPharmaceuticalRegeneronSanofiUSA

First in class novel biologic for psoriasis launched in India


Bangalore, India-based Biocon (BSE: 532523), Asia's premier biotechnology company, has launched its 'first…

ALZUMAbAsia-PacificBioconBiotechnologyDermatologicalsitolizumabMarkets & Marketing

Mayne Pharma signs up deals to market Subacap in Europe


Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Sales of psoriasis drugs to be worth $7.4 billion by 2020


The psoriasis market experienced approximately 36.5 million prevalent cases across the USA, France, Germany,…

AbbVieAmgenAsia-PacificDermatologicalsEnbrelEuropeHumiraJohnson & JohnsonMarkets & MarketingNorth AmericaNovartisPfizerPharmaceuticalsecukinumabStelara Injectiontofacitinib

US FDA approves Lupin's generic version of Teva's Seasonique and Taro's Topicort


Indian drugmaker Lupin (BSE: 500257) saw its shares gain 2.3% to 659.65 rupees by close of trading on…

DayseeDermatologicalsGenericsLupinMarkets & MarketingNorth AmericaPharmaceuticalRegulationReproductiveSeasoniqueTaro PharmaceuticalsTeva Pharmaceutical IndustriesTopicort

News briefs: Dr Reddy's launches generic Accutane; Cyprus drug shortages


Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) says it launched Zenatane (isotretinoin capsules…

AccutaneDermatologicalsDr Reddy's LaboratoriesEuropeGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalZenatane

Ranbaxy Labs' Absorica debuts in USA


Indian drugmaker Ranbaxy Laboratories (AB: BO), which is majority owned by Japan's Daiichi Sankyo, said…

AbsoricaCipher PharmaceuticalsDaiichi SankyoDermatologicalsGalephar Pharmaceutival ResearchGenericsMarkets & MarketingNorth AmericaPharmaceuticalRanbaxy Laboratories

Sinclair IS partners with Quintiles to commercialize portfolio in Mexico


UK-based Sinclair IS Pharma (AIM: SPH.L) yesterday announced the signing of a 10-year collaboration and…

DermatologicalsLicensingMarkets & MarketingPharmaceuticalQuintilesSinclair IS PharmaSouth America

US FTC updates on Valeant dermatology acquisitions


Following public comment periods for both transactions, the US Federal Trade Commission has approved…

DermatologicalsMarkets & MarketingPharmaceuticalValeant Pharmaceuticals

46% of US dermatologists expect to prescribe Pfizer’s tofacitinib to psoriasis patients who failed one biologic


In the first year following its approval for psoriasis, nearly one-half (46%) of surveyed dermatologists…

apremilastCelgeneDermatologicalsMarkets & MarketingNorth AmericaPfizerPharmaceuticaltofacitinib

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million


The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

Many European dermatologists want more post-marketing data before Rxing Pfizer’s Janus


At least half of surveyed dermatologists across the EU5 (France, Germany, Italy, Spain and the UK) will…

BiotechnologyDermatologicalsEuropeJanusMarkets & MarketingPfizerPharmaceuticaltofacitinib

Back to top